Search terms
Results 11 - 20 of 178 - ordered by :
Pages: 1 2 3 4 5 6 7 ... 18

Shokoufeh GHEZELBASH for the presentation on ''Enhanced Expression and PKCdelta-mediated Hyperphosphorylation Underlie the Proarrythmic Increase in Sodium-Calcium-Exchanger Activity in Patients with ...

Date : 26/03/2018

The clinical outcomes of noncompaction cardiomyopathy (NCCM) range from asymptomatic to heart failure, arrhythmias, and sudden cardiac death (Elliott 2008).. Genetics play an important role in NCCM ...

Date : 02/04/2018

The suspicion of myocarditis was based on symptoms suggesting inflammatory heart disease (e.g. dyspnea, palpitations, chest pain, etc.), signs of recent or ongoing myocardial damage (wall motion ...

Date : 20/09/2017

Results Median age was 41 years (interquartile range: 27 to 53 years) with similar prevalence in both sexes; pediatric cases accounted for 10.1%. Conclusion The authors conclude that EM has a poor ...

Date : 20/11/2017

Hot Topics in 2018 Ankara - Spotlight Village Sunday 26 August 11:00-12:30 Tips, Tricks and Pearls in percutaneous coronary intervention Cairo - Spotlight Village Sunday 26 August 14:30-15:45 Meet ...

Date : 04/07/2018

Hypertension also features as a session in the new Cardiology in 4 days series of lectures at the ESC, designed to provide comprehensive coverage of the entire field of cardiology in 4 days at the ...

Date : 17/07/2018

Vice-Chairperson Jan Kovac, Lead for Specialised Cardiovascular Services, University Hospitals of Leicester NHS Trust, Professor of Interventional Cardiology University of Leicester, United Kingdom ...

Date : 19/06/2018

The case EF 60% dyspnoea NYHA II and loss of performance male patient, age 61 weight: 99 kg; size: 182cm BMI: 29.89; Body surface: 2.20 m2 Test findings Spirometry ECG Derivation 9 Panel Plot of the ...

Date : 04/06/2018

The continued scientific exchange and educational collaboration between cardiologists and strokologists is essential to further improve comprehensive patient care and to advance novel treatment ...

Date : 17/05/2018

Within the DAPT trial, a high-risk score (i.e. a score ≥2) selected patients who showed a reduction in MI/stent thrombosis and cardiovascular or cerebrovascular events risk [ (NNT) for benefit for ...

Date : 30/04/2018